Bills · 118th Congress · Health

BIOSECURE Act

Where it stands

  1. Introduced5/10/24
  2. Passed HousePassed 9/9/24
  3. Senate
  4. President
  5. Law

Passed the House 306–81 on September 9, 2024 (Roll Call 402 →). Received in the Senate on September 10, 2024. No Senate action since.

Set your address to see how your representatives voted.

Roll calls on this bill

Votes on passage
HouseOn Motion to Suspend the Rules and Pass, as Amended · 9/9/24Suspension of the rulesA fast-track House procedure, usually for measures expected to have broad support. Debate is limited to 40 minutes, no amendments can be offered, and it needs a two-thirds vote of members voting — not a simple majority. A yes vote passes the bill. “As amended” means changes written into the motion itself are included.Rules of the House, Rule XV, clause 1 ↗
Passed
  • Democratic111 Yea · 79 Nay · 21 Not voting
  • Republican195 Yea · 2 Nay · 23 Not voting
  • Independent / Other0 Yea · 0 Nay · 0 Not voting
Official summary (CRS)

BIOSECURE Act

This bill prohibits entities that receive federal funds from using biotechnology that is from a company associated with a foreign adversary.

Specifically, federal agencies and recipients of federal funds (e.g., grantees) may not procure or use any biotechnology equipment or service that is from a biotechnology company of concern and may not contract with any entities that do so. A biotechnology company of concern is an entity that is under the control of a foreign adversary and that poses a risk to national security based on its research or multiomic data collection (e.g., collection of genomic information).

Full text on congress.gov ↗
Sponsor
Rep. Brad R. Wenstrup ( Republican · OH-2)
Cosponsors
14
Introduced
5/10/24
Policy area
Health

What happens next

The Senate must pass the same text, then it goes to the President.

If it isn't enacted by Jan 3, 2025, it expires when the 118th Congress ends.

All actions (13)
  1. 5/10/24Introduced in House
  2. 5/10/24Referred to the Committee on Oversight and Accountability, and in addition to the Committee on Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. 5/15/24Committee Consideration and Mark-up Session Held
  4. 5/15/24Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 1.
  5. 9/9/24Mr. Comer moved to suspend the rules and pass the bill, as amended.
  6. 9/9/24Considered under suspension of the rules. (consideration: CR H5051-5058)
  7. 9/9/24DEBATE - The House proceeded with forty minutes of debate on H.R. 8333.
  8. 9/9/24At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  9. 9/9/24Considered as unfinished business. (consideration: CR H5081-5082)
  10. 9/9/24Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)
  11. 9/9/24On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 306 - 81 (Roll no. 402). (text: CR H5051-5052)
  12. 9/9/24Motion to reconsider laid on the table Agreed to without objection.
  13. 9/10/24Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.